miR-216a/217 prompted migration and metastatic ability and increased the stem-like cells population and tumor recurrence in HCC by activation of PI3K/Akt and TGF-β pathways by induction of targeting PTEN and SMAD7 expression [185]. The gene discussed is PTEN; the disease is hepatocellular carcinoma.